GLP-1RA drugs were associated with significant benefits to neurological and behavioral health, with reduced risks of seizures and addiction to substances such as alcohol, cannabis, stimulants and opioids
Across the EVOKE and EVOKE+ trials, oral semaglutide did not slow cognitive or functional decline in 3,808 people with early Alzheimers disease, a finding that followed the Phase 3 Exenatide-PD3 trials null result in Parkinsons disease earlier that year
Vegan No MSG or Any Other Mysteries A powerful antioxidant, glutathione can decrease in our bodies as we age
When I started Ozempic, I had to start it at a very different dosage structure than they have for type 2s, Jervey said
Study results Before matching, individuals initiating incretin-based therapies differed considerably from comparator groups, particularly regarding psychiatric illnesses and psychotropic medication use